RRBGX
Price
$144.29
Change
-$0.62 (-0.43%)
Updated
Apr 17 closing price
Net Assets
53.33B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

RRBGX vs VIGRX

Header iconRRBGX vs VIGRX Comparison
Open Charts RRBGX vs VIGRXBanner chart's image
T. Rowe Price Blue Chip Growth R
Price$144.29
Change-$0.62 (-0.43%)
VolumeN/A
Net Assets53.33B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
RRBGX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RRBGX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRBGX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. RRBGX (53.3B). VIGRX pays higher dividends than RRBGX: VIGRX (0.39) vs RRBGX (0.00). RRBGX was incepted earlier than VIGRX: RRBGX (23 years) vs VIGRX (32 years). RRBGX (1.23) is less costly to investors than VIGRX (0.17). RRBGX is a more actively managed with annual turnover of: 15.70 vs. VIGRX (5.00). RRBGX has a lower initial minimum investment than VIGRX: RRBGX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. RRBGX (-3.48). VIGRX return over 5 years is better than : 99.21 vs. RRBGX (27.40).
RRBGXVIGRXRRBGX / VIGRX
Total Expense Ratio1.230.17724%
Annual Report Gross Expense Ratio1.230.17724%
Fund Existence23 years32 years-
Gain YTD-13.698-14.32696%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets53.3B261B20%
Annual Yield % from dividends0.000.39-
Returns for 1 year-3.486.01-58%
Returns for 3 years7.8730.3326%
Returns for 5 years27.4099.2128%
Returns for 10 years108.47223.8448%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics